Literature DB >> 16700041

Bone invasion in extremity soft-tissue sarcoma: impact on disease outcomes.

Peter C Ferguson1, Anthony M Griffin, Brian O'Sullivan, Charles N Catton, Aileen M Davis, Ally Murji, Robert S Bell, Jay S Wunder.   

Abstract

BACKGROUND: The purpose of the current study was to evaluate histologic bone invasion as a predictor of oncologic outcome in extremity soft-tissue sarcoma (STS) patients presenting to a specialty sarcoma center between 1986 and 2001.
METHODS: All patients who underwent surgery for extremity STS were identified from the prospective database at the study institution. Patient demographic features were compared using chi-square analyses or independent-sample Student t-tests. The disease outcomes were compared for those with and without bone invasion using Kaplan-Meier survival analysis and Cox modeling.
RESULTS: In a review of 874 patients with STS of the extremity, 48 patients (5.5%) had evidence of bone invasion. Patients with bone invasion presented with larger tumors that were more frequently deep in the extremity and more often had metastases at presentation. Patients with bone invasion had lower metastasis-free survival but bone invasion was not found to be an independent prognostic factor (P = .274) on Cox modeling. Bone invasion was found to be prognostic of overall survival on multivariate analysis (P < .0001).
CONCLUSIONS: In a small percentage of patients with STS, bone resection may be required to obtain an adequate surgical margin, thereby limiting the risk of local tumor recurrence. Histologic bone invasion portends a poorer prognosis in terms of overall survival. Copyright 2006 American Cancer Society.

Entities:  

Mesh:

Year:  2006        PMID: 16700041     DOI: 10.1002/cncr.21949

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  Tumor rupture predicts early metastasis and poor prognosis in stage III soft tissue sarcomas.

Authors:  Yong Chen; JiHui Hao; Yun Yang; JiLong Yang; XiShan Hao
Journal:  World J Surg       Date:  2011-05       Impact factor: 3.352

Review 2.  Surgical considerations when reporting MRI studies of soft tissue sarcoma of the limbs.

Authors:  Marcela De La Hoz Polo; Elizabeth Dick; Rej Bhumbra; Rob Pollock; Ranbir Sandhu; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2017-09-07       Impact factor: 2.199

3.  Soft Tissue Cancer Management: Isolated Limb Infusion for Sarcoma.

Authors:  Jyri Teras; Andrus Mägi; Marina Teras; Pille Pata; Roland M Teras; Neena Randhawa; Kristjan Kalling
Journal:  Visc Med       Date:  2019-02-13

4.  Clinical features, treatment, and outcome in 102 adult and pediatric patients with localized high-grade synovial sarcoma.

Authors:  H Al-Hussaini; D Hogg; M E Blackstein; B O'Sullivan; C N Catton; P W Chung; A M Griffin; D Hodgson; S Hopyan; R Kandel; P C Ferguson; J S Wunder; A A Gupta
Journal:  Sarcoma       Date:  2011-04-14

5.  Radiological and histopathological assessment of bone infiltration in soft tissue sarcomas.

Authors:  Luis Rodrigo Merino-Rueda; Irene Barrientos-Ruiz; Daniel Bernabeu-Taboada; José J Pozo-Kreilinger; Manuel Peleteiro-Pensado; José M Cordero-García; Eduardo J Ortiz-Cruz
Journal:  Eur J Orthop Surg Traumatol       Date:  2021-05-31

6.  Prognostic significance of histological invasion in high grade soft tissue sarcomas.

Authors:  Satoshi Tsukushi; Yoshihiro Nishida; Hiroshi Urakawa; Eiji Kozawa; Naoki Ishiguro
Journal:  Springerplus       Date:  2014-09-22

7.  Management of soft-tissue sarcomas; treatment strategies, staging, and outcomes.

Authors:  Eyal M Ramu; Matthew T Houdek; Christian E Isaac; Colleen I Dickie; Peter C Ferguson; Jay S Wunder
Journal:  SICOT J       Date:  2017-03-10

Review 8.  Soft tissue sarcomas of the upper extremities: Maximizing treatment opportunities and outcomes.

Authors:  Jose Duran-Moreno; Vasileios Kontogeorgakos; Anna Koumarianou
Journal:  Oncol Lett       Date:  2019-07-05       Impact factor: 2.967

9.  PET metabolic tumor volume as a new prognostic factor in childhood rhabdomyosarcoma.

Authors:  Helio Fayolle; Nina Jehanno; Valerie Lauwers-Cances; Marie-Pierre Castex; Daniel Orbach; Thomas Mognetti; Corradini Nadège; Pierre Payoux; Anne Hitzel
Journal:  PLoS One       Date:  2022-01-14       Impact factor: 3.240

Review 10.  Synovial Sarcoma: A Clinical Review.

Authors:  Aaron M Gazendam; Snezana Popovic; Sohaib Munir; Naveen Parasu; David Wilson; Michelle Ghert
Journal:  Curr Oncol       Date:  2021-05-19       Impact factor: 3.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.